Michael A. Levine, MD, FACS

Michael Levine, M.D. graduated with honors from Binghamton University. After receiving his degree he studied at SUNY Health Science Center in Brooklyn where he earned his Doctor of Medicine degree and graduated with a distinction in research. Dr. Levine performed his post graduate training in urology and general surgery from 1992 to 1998 at New York University Medical Center under the direction of Dr. Herbert Lepor.

Dr. Levine is one of the few surgeons on Long Island who performs minimally invasive surgery for the management of prostate cancer using the da Vinci Robot (www.intuitivesurgical.com). This procedure allows for a shortened recovery time, less blood loss and a quicker return of continence and erectile function.

Dr. Levine has extensive research experience, which has been recognized nationally and internationally. In 1992, he received an award from the National Research Forum in Galveston, Texas for his work on the treatment of advanced prostate cancer. In 1998, Dr. Levine developed a prostate biopsy technique that increases the detection of prostate cancer by 30%. These results were presented at the meeting of the Society of International Urology. Additionally, Dr. Levine collaborated on a study on blood management during radical prostatectomy for the treatment of prostate cancer. Dr. Levine has also reported on the use of minimally invasive surgical techniques for the treatment of upper urinary tract cancer. Dr. Levine’s research is published in leading peer review journals.

Dr. Levine is very active in community and hospital based educational programs. He is currently a regular speaker for Pfizer, Merck, and Pharmacia Upjohn.

He is certified by the American Board of Urology and is an active member of the American Board of Urology.